The PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid.

The PBM also announced that it will make the pharmacy experience simpler for consumers with chronic conditions by eliminating ...

Q4 2024 Earnings Call Transcript March 20, 2025 ARS Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.52, ...

In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...

The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.